Latest News and Press Releases

MIAMI, June 23, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today...

Engineered from the genomes of multiple butterfly species, Chrysalis transposase achieves high titers, stable expression, and faster cell recovery.

SALT LAKE CITY, June 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of...

ECM Therapeutics receives FDA 510(k) clearance for ECMT-100 WMD, validating its extracellular matrix hydrogel platform.

WOBURN, Mass., June 23, 2026 (GLOBE NEWSWIRE) -- Fieldstone Bio, a synthetic biology company building a new class of measurement tools for the mining industry, today announced that in partnership...

SANGAMO THERAPEUTICS ENTERS INTO ASSET SALE AGREEMENTS WITH LILLY AND ASTELLAS

KUALA LUMPUR, Malaysia, June 23, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (“Alps” or “the Company”) (Nasdaq: ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced its...

On track for enrollment of 80 participants by Q1 2027 Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer ...

U.S. Phase 2 trial met primary endpoints, with up to 11.5% weight loss at 36 weeks, showing continued weight reduction at a consistent rate and no evidence of a slowing trajectory CX11 demonstrated...

MHRA minutes from May 12 pre-MAA Scientific Advice meeting confirm agreement across all questions covering CMC, non-clinical and clinical evidence packages MHRA pediatric feedback recognizes MissionEB...